Welcome to our dedicated page for Alerian MLP Index ETN SEC filings (Ticker: AMJB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Alerian MLP Index ETN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Alerian MLP Index ETN's regulatory disclosures and financial reporting.
J.P. Morgan published a prospectus supplement and index update for the S&P® Global 100 PR 5% Daily Risk Control 0.5% Deduction Index (USD) ER, providing hypothetical backtested monthly returns from November 20, 1996 through September 17, 2023 and actual performance from September 18, 2023 through February 28, 2026. The document shows monthly and annual return series, notes a 0.50% per annum index deduction and notional financing cost deducted daily, and lists selected risks including potential deviation from target volatility and periods when the Index may be significantly uninvested.
The update emphasizes that backtested results are hypothetical and not indicative of future performance and refers readers to the related disclosure materials and risk sections for full details.
JPMorgan Chase & Co. provides an index supplement and prospectus updates presenting hypothetical backtested returns from December 31, 1998 through May 12, 2009 and actual index performance from May 13, 2009 through February 28, 2026 for the S&P 500® Daily Risk Control 10% Index. The materials include monthly and annual return tables, disclose that backtests use proxies and that the Index targets a 10% volatility, and warn that past and backtested performance are not indicative of future results.
The supplement lists selected risks, including that the Index may not meet the 10% target, may be uninvested at times, and reflects a deducted notional financing cost; it also notes a recent change to the financing-cost methodology.
JPMorgan Chase Financial Company LLC priced a $610,000 offering of Auto Callable Contingent Interest Notes linked to the MerQube US Large-Cap Vol Advantage Index, due March 11, 2031, fully and unconditionally guaranteed by JPMorgan Chase & Co.
The notes pay monthly Contingent Interest Payments when the Index closes at or above an Interest Barrier of 70.00% of the Initial Value, are subject to a 6.0% per annum daily deduction, and will be automatically called if the Index on any quarterly Autocall Review Date is at or above the Initial Value; the earliest Autocall date is September 8, 2026. The notes priced on March 6, 2026 with an original issue price of $1,000 per note and an estimated value of $929.20 per $1,000 principal amount.
AMJB supplement provides hypothetical backtested and actual historical monthly and annual returns for the MerQube US Small‑Cap Vol Advantage Index, covering backtested performance from January 7, 2005 through June 17, 2022 and actual performance from June 21, 2022 through February 28, 2026. The materials state the Index level reflects a 6.0% per annum daily deduction and note the Index was established on June 21, 2022. The supplement emphasizes that backtested results have limitations and that past or backtested performance is not indicative of future results.
J.P. Morgan Securities LLC provides a performance update for the MerQube US Tech+ Vol Advantage Index, describing its construction, a 6.0% per annum daily deduction, replacement of E-Mini Nasdaq-100 futures with an unfunded position in the Invesco QQQ Trust effective February 9, 2024, and hypothetical/backtested performance through February 2026.
The update discloses historical returns and volatilities (Feb 2016–Feb 2026), recent end-of-day exposures ranging above 100% through early 2026, and prominent risk disclosures including leverage risk, index sponsor discretion, and limitations of backtested results.
JPMorgan Chase Financial Company LLC is offering structured notes linked to the MerQube US Tech+ Vol Advantage Index due March 27, 2031, fully guaranteed by JPMorgan Chase & Co.
The notes may be automatically called beginning March 25, 2027. They provide a series of escalating Call Premium Amounts up to 57.50% (final Review Date) but include a 15.00% buffer at maturity. Investors may forgo interest and dividends and can lose up to 85.00% of principal if the Index declines beyond the buffer. The Index applies a 6.0% per annum daily deduction and a notional financing cost; the estimated note value at pricing is approximately $908.90 per $1,000 principal amount, with a minimum estimated value of $900.00.
J.P. Morgan published a monthly performance update for the MerQube US Small‑Cap Vol Advantage Index, a rules‑based index that targets a level volatility of 35% and applies a 6.0% per annum daily deduction. The Index permits exposures to E‑Mini Russell 2000 futures between 0% and 500% and was established on June 21, 2022. Levels are published on Bloomberg under ticker MQUSSVA. The update presents hypothetical backtested performance (Feb 2016–June 17, 2022) and actual performance (from June 21, 2022 through February 28, 2026), and shows recent end‑of‑day exposures in early 2026 ranging from 122.75% to 148.84% in February.
JPMorgan Chase Financial Company LLC is offering structured notes linked to the least performing of the Dow Jones Industrial Average, Nasdaq-100 and Russell 2000 due March 18, 2030. The notes have a $1,000 principal amount per note, are expected to price on or about March 13, 2026, and to settle on or about March 18, 2026.
The notes can be automatically called beginning on March 18, 2027 on specified Review Dates for the principal plus a staged Call Premium (ranging from $155 to $620 per $1,000 note in the examples). If not called, a Barrier at 70.00% of each Index’s Initial Value protects principal only if each Index’s Final Value is at or above that Barrier; otherwise the maturity payment equals $1,000 plus $1,000 times the Least Performing Index Return and you may lose up to all principal.
JPMorgan Chase Financial Company LLC is offering Capped Dual Directional Buffered Equity Notes linked to the S&P 500® Index due March 9, 2028, fully guaranteed by JPMorgan Chase & Co.
The notes feature a 20.00% buffer against index declines, a Maximum Upside Return of at least 18.40%, a Strike Value of 6,740.02 (as of March 6, 2026), an Observation Date of March 6, 2028, expected Pricing Date on or about March 10, 2026, and settlement on or about March 13, 2026. Minimum denomination is $1,000. The estimated value at pricing would be approximately $987.80 per $1,000 note (not less than $950.00 per note). Payments depend on the Index Return with capped upside if positive, absolute-return treatment up to the buffer if modestly negative, and loss beyond the buffer (up to an 80.00% principal loss). Credit risk is borne by JPMorgan Financial and JPMorgan Chase & Co.
AMJB — Index update and historical performance summary. This supplement provides hypothetical backtested monthly and annual returns for the S&P 500® Daily Risk Control 5% Index covering January 4, 1999 through February 28, 2026 (backtest through September 9, 2009, actual thereafter). The presentation cautions that backtested results were produced using proxies, that past performance is not indicative of future results, and that the Index’s methodology and notional financing cost have changed.
The document lists selected risks, including that the Index may not meet its 5% target volatility, may be significantly uninvested at times, and that daily exposure adjustments can limit upside or magnify downside. It also directs readers to the related offering documents and risk sections for further details.